Does DIVALPROEX Cause Hyperammonaemic encephalopathy? 119 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Hyperammonaemic encephalopathy have been filed in association with DIVALPROEX (Divalproex Sodium). This represents 1.0% of all adverse event reports for DIVALPROEX.
119
Reports of Hyperammonaemic encephalopathy with DIVALPROEX
1.0%
of all DIVALPROEX reports
9
Deaths
73
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From DIVALPROEX?
Of the 119 reports, 9 (7.6%) resulted in death, 73 (61.3%) required hospitalization, and 14 (11.8%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIVALPROEX. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does DIVALPROEX Cause?
Drug ineffective (1,121)
Seizure (1,095)
Off label use (576)
Somnolence (545)
Drug interaction (540)
Nausea (526)
Weight increased (509)
Tremor (461)
Toxicity to various agents (452)
Vomiting (436)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
CAPECITABINE (60)
Which DIVALPROEX Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
DIVALPROEX vs DOBUTAMINE
DIVALPROEX vs DOBUTAMINE\DOBUTAMINE
DIVALPROEX vs DOCETAXEL
DIVALPROEX vs DOCETAXEL ANHYDROUS
DIVALPROEX vs DOCETAXEL\DOCETAXEL ANHYDROUS